» Articles » PMID: 20170791

African-American Women Have a Higher Risk for Developing Peripartum Cardiomyopathy

Overview
Date 2010 Feb 23
PMID 20170791
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The purpose of this study was to assess whether African-American women are at increased risk of having peripartum cardiomyopathy.

Background: Peripartum cardiomyopathy is a heart disease of unknown cause that affects young women, often with devastating consequences. The frequency of peripartum cardiomyopathy varies markedly between African and non-African regions.

Methods: A case-control study was performed at a regional center that provides medical care to a racially heterogeneous population. For each case, 3 healthy control patients were randomly selected who delivered babies within the same month.

Results: African-American women had a 15.7-fold higher relative risk of peripartum cardiomyopathy than non-African Americans (odds ratio [OR]: 15.7, 95% confidence interval [CI]: 3.5 to 70.6). Other significant univariate risk factors were hypertension (OR: 10.8, 95% CI: 2.6 to 44.4), being unmarried (OR: 4.2, 95% CI: 1.4 to 12.3), and having had >2 previous pregnancies (OR: 2.9, 95% CI: 1.1 to 7.4). African-American ethnicity remained a significant risk factor for peripartum cardiomyopathy when other risk factors were considered in multivariable (OR: 31.5, 95% CI: 3.6 to 277.6) and stratified analyses (OR: 12.9 to 29.1, p < 0.001). Although the frequency of peripartum cardiomyopathy (185 of 100,000 deliveries) at this center was higher than in previous U.S. reports, it was comparable to the frequency in countries with more women of African descent (100 to 980 of 100,000). Analysis of other U.S. studies confirmed that the frequency of peripartum cardiomyopathy was significantly higher among African-American women.

Conclusions: African-American women have significantly higher odds of having peripartum cardiomyopathy that could not be explained by several other factors. Further research will be necessary to determine the potential environmental and/or genetic factors associated with African descent that confer this risk.

Citing Articles

Diagnosis and management of peripartum cardiomyopathy and recurrence risk.

Iannaccone G, Graziani F, Kacar P, Tamborrino P, Lillo R, Montanaro C Int J Cardiol Congenit Heart Dis. 2024; 17:100530.

PMID: 39711771 PMC: 11657248. DOI: 10.1016/j.ijcchd.2024.100530.


What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow.

Lasica R, Asanin M, Vukmirovic J, Maslac L, Savic L, Zdravkovic M Int J Mol Sci. 2024; 25(19).

PMID: 39408885 PMC: 11477285. DOI: 10.3390/ijms251910559.


Peripartum cardiomyopathy: a comprehensive and contemporary review.

Sigauke F, Ntsinjana H, Tsabedze N Heart Fail Rev. 2024; 29(6):1261-1278.

PMID: 39348083 PMC: 11455798. DOI: 10.1007/s10741-024-10435-5.


Cardiovascular Risk Assessment as a Quality Measure in the Pregnancy and Postpartum Period.

Hameed A, Tarsa M, Graves C, Chang J, Billah M, Hatfield T JACC Adv. 2024; 2(1):100176.

PMID: 38939026 PMC: 11198421. DOI: 10.1016/j.jacadv.2022.100176.


Cardiomyopathies in Women.

Martin C Methodist Debakey Cardiovasc J. 2024; 20(2):59-69.

PMID: 38495661 PMC: 10941701. DOI: 10.14797/mdcvj.1368.


References
1.
Chee K, Azman W . Prevalence and outcome of peripartum cardiomyopathy in Malaysia. Int J Clin Pract. 2007; 63(5):722-5. DOI: 10.1111/j.1742-1241.2007.01449.x. View

2.
Isezuo S, Abubakar S . Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis. 2007; 17(2):228-33. View

3.
Demakis J, Rahimtoola S, Sutton G, MEADOWS W, SZANTO P, Tobin J . Natural course of peripartum cardiomyopathy. Circulation. 1971; 44(6):1053-61. DOI: 10.1161/01.cir.44.6.1053. View

4.
Ford R, Barton J, OBrien J, Hollingsworth P . Demographics, management, and outcome of peripartum cardiomyopathy in a community hospital. Am J Obstet Gynecol. 2000; 182(5):1036-8. DOI: 10.1067/mob.2000.105402. View

5.
Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P . Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol. 2000; 35(3):701-5. DOI: 10.1016/s0735-1097(99)00624-5. View